Close Menu

Beckman Coulter

The suit, which centered around SNP genotyping technologies and patents, was dismissed a couple of weeks after a Markman hearing in the case.

Beckman Coulter's first-quarter revenues fell 5.3 percent, but were flat in constant currency terms, as the firm's cash instrument sales declined. The firm's life science and cellular analysis instruments were hit particularly hard by the constrained capital expenditure market.

PGx & molecular Dx

BioArray Briefs: 2009.04.21

Premium

Illumina, Agilent Technologies, Roche NimbleGen, Sigma Aldrich, DNAVision, BioTek, Promega, Decode Genetics, Clinical Data, Cogenics, Beckman Coulter

Snippets: Apr 15, 2009

Premium

Decode Genetics, National Cancer Institute, Clinical Data, Beckman Coulter, Department of Veterans Affairs, Genetics and Public Policy Center, National Institute of Child Health and Human Development

The firms completed the deal only two weeks after announcing an agreement. The acquisition is valued at $17 million.

The approximately $17 million acquisition, announced last week, will have "no impact" on Clinical Data's focus as a pharmacogenomics company, according to CEO Drew Fromkin.

Up until now, Agencourt's main focus has been on DNA sequencing and sample prep. Cogenics, which has facilities in four countries, also provides genotyping, gene-expression analysis, biological efficacy and safety testing, and a biobanking facility.

BioArray Briefs: 2009.04.07

Premium

CGC Genetics, Nuvera Biosciences, Veridex, ImaGenes, CapitalBio, Fisher Healthcare, Osmetech, National Institutes of Health, Clinical Data, Cogenics, UK Biotechnology and Biological Sciences Research Council

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Pages

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.